ad image

Osteoporosis

1 / 1
Amgen
Drug Development

EVENITY™ (romosozumab-aqqg) Now Available In The United States For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture

Amgen

PR-M04-19-NI-054Apr 17, 2019
U.S. Food & Drug Administration
FDA Approval

FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture

U.S. Food & Drug Administration

PR-M04-19-NI-041Apr 12, 2019
1 / 1